Litcius/Paper detail

Efficacy and Safety of Pioglitazone Add-on in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Metformin and Dapagliflozin: A Multicenter, Randomized, Double-blind, and Placebo-controlled Study

Yun Kyung Cho, Kyung Soo Kim, Byung‐Wan Lee, Jun Hwa Hong, Jae Myung Yu, Soo Lim, Ye An Kim, Chang Beom Lee, Sang Soo Kim, Soo Heon Kwak, Woo Je Lee

2024Clinical Therapeutics13 citationsDOIOpen Access PDF

Topics & Concepts

DapagliflozinMedicineMetforminPioglitazoneType 2 diabetesPlaceboDiabetes mellitusType 2 Diabetes MellitusPlacebo-controlled studyInternal medicineRandomized controlled trialDouble blindEndocrinologyAlternative medicinePathologyDiabetes Treatment and ManagementMetabolism, Diabetes, and CancerDiabetes, Cardiovascular Risks, and Lipoproteins
Efficacy and Safety of Pioglitazone Add-on in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Metformin and Dapagliflozin: A Multicenter, Randomized, Double-blind, and Placebo-controlled Study | Litcius